The Biopharmaceutical Third-Party Logistics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the biopharmaceutical third-party logistics has seen substantial growth recently. The market is expected to increase from $141.59 billion in 2024 to $150.94 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%.
The anticipated market size of the biopharmaceutical third-party logistics market by 2029 is projected to be $203.7 billion. The compound annual growth rate (CAGR) over the period is expected to be 7.8%.
Download Your Free Sample of the 2025 Biopharmaceutical Third-Party Logistics Market Report and Uncover Key Trends Now!The key drivers in the biopharmaceutical third-party logistics market are:
• Expansion of personalized medicine
• Growth in biologics and biosimilars
• Digitization of supply chain processes
• Increasing complexity of regulatory compliance
The biopharmaceutical third-party logistics market covered in this report is segmented –
1) By Supply Chain: Cold Chain, Non-Cold Chain
2) By Service: Transportation, Warehousing And Storage, Other Services
3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users
The key trends in the biopharmaceutical third-party logistics market are:
• Personalized medicine growth is shaping the future of biopharmaceutical third-party logistics.
• Expansion of biologics and biosimilars is a key trend in the market.
• There's an increasing trend towards digitalization of the supply chain.
• complexities in regulatory compliance are profoundly influencing the market.
The major players in the biopharmaceutical third-party logistics market are:
• McKesson Corporation
• AmerisourceBergen Corporation
• United Parcel Service of America Inc
North America was the largest region in the biopharmaceutical third party logistics market in 2024